Clinical and immunological features in a cohort of patients with partial DiGeorge syndrome followed at a single center
- PMID: 31015189
- DOI: 10.1182/blood.2018885244
Clinical and immunological features in a cohort of patients with partial DiGeorge syndrome followed at a single center
Abstract
DiGeorge syndrome (DGS) is a primary immunodeficiency characterized by various degrees of T-cell deficiency. In partial DGS (pDGS), other risk factors could predispose to recurrent infections, autoimmunity, and allergy. The aim of this study was to assess the effect of different factors in the development of infections, autoimmunity, and/or allergy in patients with pDGS. We studied 467 pDGS patients in follow-up at Great Ormond Street Hospital. Using a multivariate approach, we observed that palatal anomalies represent a risk factor for the development of recurrent otitis media with effusion. Gastroesophageal reflux/dysphagia and asthma/rhinitis represent a risk factor for the development of recurrent upper respiratory tract infections. Allergy and autoimmunity were associated with persistently low immunoglobulin M levels and lymphopenia, respectively. Patients with autoimmunity showed lower levels of CD3+, CD3+CD4+, and naïve CD4+CD45RA+CD27+ T lymphocytes compared with pDGS patients without autoimmunity. We also observed that the physiological age-related decline of the T-cell number was slower in pDGS patients compared with age-matched controls. The age-related recovery of the T-cell number depended on a homeostatic peripheral proliferation of T cells, as suggested by an accelerated decline of the naïve T lymphocytes in pDGS as well as a more skewed T-cell repertoire in older pDGS patients. These evidences suggest that premature CD4+ T-cell aging and lymphopenia induced spontaneous peripheral T-cell proliferation might contribute to the pathogenesis of autoimmunity in patients with pDGS. Infections in these patients represent, in most of the cases, a complication of anatomical or gastroenterological anomalies rather than a feature of the underlying immunodeficiency.
© 2019 by The American Society of Hematology.
Similar articles
-
Relationship Between Severity of T Cell Lymphopenia and Immune Dysregulation in Patients with DiGeorge Syndrome (22q11.2 Deletions and/or Related TBX1 Mutations): a USIDNET Study.J Clin Immunol. 2021 Jan;41(1):29-37. doi: 10.1007/s10875-020-00854-y. Epub 2020 Sep 19. J Clin Immunol. 2021. PMID: 32949294
-
Thymic Epithelium Abnormalities in DiGeorge and Down Syndrome Patients Contribute to Dysregulation in T Cell Development.Front Immunol. 2019 Mar 15;10:447. doi: 10.3389/fimmu.2019.00447. eCollection 2019. Front Immunol. 2019. PMID: 30949166 Free PMC article. Clinical Trial.
-
Development of specific T-cell responses to Candida and tetanus antigens in partial DiGeorge syndrome.J Allergy Clin Immunol. 2008 Dec;122(6):1194-9. doi: 10.1016/j.jaci.2008.06.039. Epub 2008 Sep 13. J Allergy Clin Immunol. 2008. PMID: 18789819
-
The DiGeorge syndrome. I. Clinical evaluation and course of partial and complete forms of the syndrome.Eur J Pediatr. 1988 Jun;147(5):496-502. doi: 10.1007/BF00441974. Eur J Pediatr. 1988. PMID: 3044796 Review.
-
The immune deficiency of chromosome 22q11.2 deletion syndrome.Am J Med Genet A. 2017 Sep;173(9):2366-2372. doi: 10.1002/ajmg.a.38319. Epub 2017 Jun 19. Am J Med Genet A. 2017. PMID: 28627729 Review.
Cited by
-
Cellular and molecular mechanisms breaking immune tolerance in inborn errors of immunity.Cell Mol Immunol. 2021 May;18(5):1122-1140. doi: 10.1038/s41423-020-00626-z. Epub 2021 Apr 1. Cell Mol Immunol. 2021. PMID: 33795850 Free PMC article. Review.
-
Primary and secondary defects of the thymus.Immunol Rev. 2024 Mar;322(1):178-211. doi: 10.1111/imr.13306. Epub 2024 Jan 16. Immunol Rev. 2024. PMID: 38228406 Free PMC article. Review.
-
Distinct Immunophenotypic Features in Patients Affected by 22q11.2 Deletion Syndrome with Immune Dysregulation and Infectious Phenotype.J Clin Med. 2023 Dec 8;12(24):7579. doi: 10.3390/jcm12247579. J Clin Med. 2023. PMID: 38137647 Free PMC article.
-
Case report: Effectiveness of sirolimus in treating partial DiGeorge Syndrome with Autoimmune Lymphoproliferative Syndrome (ALPS)-like features.Front Pediatr. 2023 Jan 18;10:1014249. doi: 10.3389/fped.2022.1014249. eCollection 2022. Front Pediatr. 2023. PMID: 36741091 Free PMC article.
-
Current and Future Therapeutic Approaches for Thymic Stromal Cell Defects.Front Immunol. 2021 Mar 18;12:655354. doi: 10.3389/fimmu.2021.655354. eCollection 2021. Front Immunol. 2021. PMID: 33815417 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials